Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Spectrum Beta-lactamases - Treatment, Carriage, Environmental Dissemination And Population Epidemiology

NCT01838213 is registered in ClinicalTrials.gov with Vestre Viken Hospital Trust as lead sponsor.

NCT NCT01838213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01838213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Spectrum Beta-lactamases - Treatment, Carriage, Environmental Dissemination And Population Epidemiology
Lead sponsor
Vestre Viken Hospital Trust
Phase
Observational
Overall status
Completed
Start date
February 28, 2009
Completion date
Not reported
Enrollment
760 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

environmental contamination of esbl, infection due to esbl bacteria, urinary tract infection